Perivascular fat, AMP‐activated protein kinase and vascular diseases
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Perivascular adipose tissue (PVAT) is an active endocrine and paracrine organ that modulates vascular function, with implications for the pathophysiology of cardiovascular disease (CVD). Adipocytes and stromal cells contained within PVAT produce mediators (adipokines, cytokines, reactive oxygen species and gaseous compounds) with a range of paracrine effects modulating vascular smooth muscle cell contraction, proliferation and migration. However, the modulatory effect of PVAT on the vascular system in diseases, such as obesity, hypertension and atherosclerosis, remains poorly characterized. AMP‐activated protein kinase (AMPK) regulates adipocyte metabolism, adipose biology and vascular function, and hence may be a potential therapeutic target for metabolic disorders such as type 2 diabetes mellitus (T2DM) and the vascular complications associated with obesity and T2DM. The role of AMPK in PVAT or the actions of PVAT have yet to be established, however. Activation of AMPK by pharmacological agents, such as metformin and thiazolidinediones, may modulate the activity of PVAT surrounding blood vessels and thereby contribute to their beneficial effect in cardiometabolic diseases. This review will provide a current perspective on how PVAT may influence vascular function via AMPK. We will also attempt to demonstrate how modulating AMPK activity using pharmacological agents could be exploited therapeutically to treat cardiometabolic diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
European Guidelines for Obesity Management in Adults
Yumuk, V., Tsigos, C., Fried, M., Schindler, K., Busetto, L., Micic, D., & Toplak, H. (2015) · Obesity Facts · doi:10.1159/000442721 · Cited by 3,432
Kahn, B. B., Alquier, T., Carling, D., & Hardie, D. G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2004.12.003 · Cited by 2,799 · cited 1×
“Thus, the tissue-specific subunit composition may be important to determine a specialized cellular and systemic response to different metabolic stimuli (Kahn et al., 2005).”
BackgroundAdipose tissue, adipokines, and inflammation
Fantuzzi, G. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.02.023 · Cited by 2,606 · cited 1×
“Furthermore, in obese animals, administration of adiponectin has been found to improve insulin sensitivity and to decrease hyperglycaemia and the level of fatty acids in the plasma (Berg et al., 2002; Fantuzzi, 2005).”
BackgroundLeptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase
Minokoshi, Y., Kim, Y.-B., Peroni, O. D., Fryer, L. G. D., Müller, C., Carling, D., & Kahn, B. B. (2002) · Nature · doi:10.1038/415339a · Cited by 2,053 · cited 7×
“, 2005) and humans (Minokoshi et al., 2002) in comparison with lean controls.”
BackgroundResultInfluentialThe Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin
Shaw, R. J., Lamia, K. A., Vasquez, D., Koo, S.-H., Bardeesy, N., DePinho, R. A., Montminy, M., & Cantley, L. C. (2005) · Science · doi:10.1126/science.1120781 · Cited by 1,950 · cited 1×
“In human type 2 diabetic skeletal muscle, AMPK expression and activity are also unchanged in patients with a similar body mass (Shaw et al., 2005).”
BackgroundKern, P. A., Ranganathan, S., Li, C., Wood, L., & Ranganathan, G. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.5.e745 · Cited by 1,883 · cited 1×
“AICAR has also been reported to stimulate release of adiponectin and inhibit release of cytokines such as TNF-α and IL-6, which have been implicated in the development of obesity-induced insulin resistance (Kern et al., 2001; Lihn et al., 2004).”
BackgroundUnexpected evidence for active brown adipose tissue in adult humans
Nedergaard, J., Bengtsson, T., & Cannon, B. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00691.2006 · Cited by 1,824 · cited 1×
“Fat cells in BAT are larger in size with multiple small lipid droplets and larger numbers of mitochondria (Cinti, 2005; Nedergaard et al., 2007).”
BackgroundHawley, S. A., Pan, D. A., Mustard, K. J., Ross, L., Bain, J., Edelman, A. M., Frenguelli, B. G., & Hardie, D. G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.009 · Cited by 1,589 · cited 1×
“The combination of allosteric modulation and phosphorylation leads to a >1000-fold increase in kinase activity (Hawley et al., 2005; Xie et al., 2006).”
BackgroundStatin Therapy, LDL Cholesterol, C-Reactive Protein, and Coronary Artery Disease
Nissen, S. E., Tuzcu, E. M., Schoenhagen, P., Crowe, T., Sasiela, W. J., Tsai, J., Orazem, J., Magorien, R. D., O'Shaughnessy, C., & Ganz, P. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042000 · Cited by 1,325
Interleukin-6-deficient mice develop mature-onset obesity
Wallenius, V., Wallenius, K., Ahrén, B., Rudling, M., Carlsten, H., Dickson, S. L., Ohlsson, C., & Jansson, J.-O. (2002) · Nature Medicine · doi:10.1038/nm0102-75 · Cited by 1,213 · cited 2×
“However, IL-6 knockout in mice can be linked with the development of mature-onset obesity (Wallenius et al., 2002) and diet-induced atherosclerosis (Madan et al., 2008), an effect that can be attributed to the reduced AMPK activity in IL-6-deficient mice (Kelly et al., 2004).”
BackgroundForetz, M., Hébrard, S., Leclerc, J., Zarrinpashneh, E., Soty, M., Mithieux, G., Sakamoto, K., Andreelli, F., & Viollet, B. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40671 · Cited by 1,181 · cited 1×
“However, more recent studies have demonstrated that AMPK activity is completely dispensable for the anti-gluconeogenic action (Foretz et al., 2010), yet it remains possible that AMPK activation underlies other effects of metformin.”
BackgroundObesity, inflammation, and atherosclerosis
Rocha, V. Z., & Libby, P. (2009) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2009.55 · Cited by 994
Structure of mammalian AMPK and its regulation by ADP
Xiao, B., Sanders, M. J., Underwood, E., Heath, R., Mayer, F. V., Carmena, D., Jing, C., Walker, P. A., Eccleston, J. F., Haire, L. F., et al. (2011) · Nature · doi:10.1038/nature09932 · Cited by 926 · cited 7×
“Within the activation loop of the kinase domain is a threonine residue (Thr172), whose phosphorylation by upstream kinases is required for activation (Hawley et al., 1996).”
BackgroundInfluentialMusi, N., Hirshman, M. F., Nygren, J., Svanfeldt, M., Bavenholm, P., Rooyackers, O., Zhou, G., Williamson, J. M., Ljunqvist, O., Efendic, S., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2074 · Cited by 806 · cited 1×
“…is essential for the maintenance of cardiovascular health, has a regulatory role over vascular structure and function, and is activated by several pathological stimuli, including oxidative damage, ischaemia, hypoxia/anoxia and cardiac hypertrophy (Nagata and Hirata, 2010; Ewart and Kennedy, 2011).”
BackgroundUse of Cells Expressing γ Subunit Variants to Identify Diverse Mechanisms of AMPK Activation
Hawley, S. A., Ross, F. A., Chevtzoff, C., Green, K. A., Evans, A., Fogarty, S., Towler, M. C., Brown, L. J., Ogunbayo, O. A., Evans, A. M., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.04.001 · Cited by 773 · cited 2×
“, 2008), and recent studies utilizing AMPKγ mutants that are insensitive to AMP have shown that AMP increases are also essential for metformin-stimulated AMPK activity (Hawley et al., 2010).”
BackgroundOuchi, N., Kobayashi, H., Kihara, S., Kumada, M., Sato, K., Inoue, T., Funahashi, T., & Walsh, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310389200 · Cited by 759 · cited 2×
“It has been shown that AMPK signalling mediates adiponectininduced angiogenic and anti-apoptotic cellular responses in British Journal of Pharmacology (2014) 171 595–617 607 endothelial cells (Kobayashi et al., 2004; Ouchi et al., 2004).”
BackgroundScott, J. W., Hawley, S. A., Green, K. A., Anis, M., Stewart, G., Scullion, G. A., Norman, D. G., & Hardie, D. G. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19874 · Cited by 754
Metformin reverses fatty liver disease in obese, leptin-deficient mice.
Lin, H. Z., Yang, S. Q., Chuckaree, C., Kuhajda, F., Ronnet, G., & Diehl, A. M. (2000) · Nature Medicine · doi:10.1038/79697 · Cited by 673 · cited 2×
“Similarly, AICAR has been demonstrated to increase AMPK activity to a similar degree in obese skeletal muscle from rodents (Lin et al., 2000; Pold et al., 2005) and humans (Minokoshi et al., 2002) in comparison with lean controls.”
BackgroundCharacterization of AMP-activated protein kinase γ-subunit isoforms and their role in AMP binding
CHEUNG, P. C. F., SALT, I. P., DAVIES, S. P., HARDIE, D. G., & CARLING, D. (2000) · Biochemical Journal · doi:10.1042/bj3460659 · Cited by 637
Self-citationMacrophage Autophagy Plays a Protective Role in Advanced Atherosclerosis
Liao, X., Sluimer, J. C., Wang, Y., Subramanian, M., Brown, K., Pattison, J. S., Robbins, J., Martinez, J., & Tabas, I. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.01.022 · Cited by 627
Marx, N., Duez, H., Fruchart, J.-C., & Staels, B. (2004) · Circulation Research · doi:10.1161/01.res.0000127122.22685.0a · Cited by 501
Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF
Cao, R., Brakenhielm, E., Wahlestedt, C., Thyberg, J., & Cao, Y. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.101564798 · Cited by 446 · cited 1×
“, 2007) ↑ Vascular permeability (Cao et al., 2001) ↑ TNF-α, IL-6, IL-12, ROS (Fitzgibbons et al.”
Zhuang, G., Meng, C., Guo, X., Cheruku, P. S., Shi, L., Xu, H., Li, H., Wang, G., Evans, A. R., Safe, S., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.087817 · Cited by 428
AMPK β Subunit Targets Metabolic Stress Sensing to Glycogen
Polekhina, G., Gupta, A., Michell, B. J., van Denderen, B., Murthy, S., Feil, S. C., Jennings, I. G., Campbell, D. J., Witters, L. A., Parker, M. W., et al. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00292-6 · Cited by 423 · cited 1×
“The β subunit comprises a C-terminal domain required for association with the α subunit (Wong and Lodish, 2006) and a central region for glycogen binding (Polekhina et al., 2003).”
BackgroundCalvert, J. W., Gundewar, S., Jha, S., Greer, J. J. M., Bestermann, W. H., Tian, R., & Lefer, D. J. (2008) · Diabetes · doi:10.2337/db07-1098 · Cited by 422
Rivera, L., Morón, R., Zarzuelo, A., & Galisteo, M. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.11.027 · Cited by 391 · cited 1×
“Long-term administration of AICAR or resveratrol, which has been described as an activator of AMPK, also caused a reduction in MAP in obese Zucker rats (Buhl et al., 2002; Rivera et al., 2009).”
BackgroundYang, S.-R., Wright, J., Bauter, M., Seweryniak, K., Kode, A., & Rahman, I. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00308.2006 · Cited by 391 · cited 1×
“Generally, stimulation of macrophages by pro-inflammatory stimuli decreases sirtuin levels, which is associated with increased activation of RelA/p65 subunit of NF-κB and increased pro-inflammatory cytokine release (Yang et al., 2007).”
BackgroundSanders, M. J., Ali, Z. S., Hegarty, B. D., Heath, R., Snowden, M. A., & Carling, D. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706543200 · Cited by 347 · cited 2×
“In addition, A769662 activation of AMPK was inhibited by a mutation in the β1 AMPK subunit (Ser108 to Ala), which is an auto-phosphorylation site within the glycogen-binding domain; however, the same mutation only partially reduced AMPK activation by AMP (Cool et al., 2006; Sanders et al., 2007).”
BackgroundHypoxia signals autophagy in tumor cells via AMPK activity, independent of HIF-1, BNIP3, and BNIP3L
Papandreou, I., Lim, A. L., Laderoute, K., & Denko, N. C. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.84 · Cited by 334 · cited 2×
“AMPK also plays a pivotal role in hypoxia-induced autophagy in human cancer cell lines (Papandreou et al., 2008) and human pulmonary artery SMCs exposed to hypoxia (Ibe et al., 2013).”
BackgroundKramer, H. F., Witczak, C. A., Fujii, N., Jessen, N., Taylor, E. B., Arnolds, D. E., Sakamoto, K., Hirshman, M. F., & Goodyear, L. J. (2006) · Diabetes · doi:10.2337/db06-0150 · Cited by 315 · cited 1×
“Whereas AMPK activation in skeletal muscle is proven to increase glucose transporter type 4 (GLUT-4) translocation and, therefore, both basal and insulin-stimulated glucose transport (Kramer et al., 2006; Fazakerley et al., 2010), AMPK activation in adipose tissue has yielded contrasting results.”
ResultWang, S., Zhang, M., Liang, B., Xu, J., Xie, Z., Liu, C., Viollet, B., Yan, D., & Zou, M.-H. (2010) · Circulation Research · doi:10.1161/circresaha.109.212530 · Cited by 296 · cited 2×
“, 2005), although an important role for α2 cannot be excluded as down-regulation of this isoform can have marked effects on adipocyte function (Wang et al., 2010).”
BackgroundIglesias, M. A., Ye, J.-M., Frangioudakis, G., Saha, A. K., Tomas, E., Ruderman, N. B., Cooney, G. J., & Kraegen, E. W. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2886 · Cited by 290 · cited 2×
“AICAR has been demonstrated to reverse many aspects of the metabolic syndrome in animal models such as the ob/ob mouse, the fa/fa rat and high fat-fed rat (Buhl et al., 2002; Iglesias et al., 2002), and also in human subjects (Cuthbertson et al., 2007).”
BackgroundAMPK activity is diminished in tissues of IL-6 knockout mice: the effect of exercise.
Kelly, M., Keller, C., Avilucea, P. R., Keller, P., Luo, Z., Xiang, X., Giralt, M., Hidalgo, J., Saha, A. K., Pedersen, B. K., et al. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.05.188 · Cited by 289
Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues
LeBrasseur, N. K., Kelly, M., Tsao, T.-S., Farmer, S. R., Saha, A. K., Ruderman, N. B., & Tomas, E. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00453.2005 · Cited by 276 · cited 1×
“The acute effects of TZDs have been proposed to be via activation of AMPK in adipose tissue, skeletal muscle and liver (LeBrasseur et al., 2006).”
BackgroundXie, Z., Dong, Y., Scholz, R., Neumann, D., & Zou, M.-H. (2008) · Circulation · doi:10.1161/circulationaha.107.744490 · Cited by 273 · cited 2×
“AMPK activators, such as AICAR (Mariman and Wang, 2010), metformin (Xie et al., 2008) and rosiglitazone (Boyle et al., 2008), have been reported to directly activate AMPK and enhance NO production in human endothelial cells.”
BackgroundPerivascular adipose tissue: More than just structural support
Szasz, T., & Webb, R. C. (2012) · Clinical Science · doi:10.1042/cs20110151 · Cited by 265 · cited 1×
“…macrophages and T lymphocytes, fibroblasts and capillary endothelial cells, which are normally found in PVAT or attracted in response to inflammatory chemokines released by adipocytes, have also been demonstrated to contribute to the secretory profile of adipose tissue (see Szasz and Webb, 2012).”
BackgroundAMP-activated protein kinase functionally phosphorylates endothelial nitric oxide synthase Ser633
Chen, Z., Peng, I.-C., Sun, W., Su, M.-I., Hsu, P.-H., Fu, Y., Zhu, Y., DeFea, K., Pan, S., Tsai, M.-D., et al. (2009) · Circulation Research · doi:10.1161/circresaha.108.187567 · Cited by 264 · cited 2×
“In the vasculature, activation of endothelial AMPK has been shown to phosphorylate eNOS at Ser1177 and Ser633, stimulating NO release (Chen et al., 2009; Mariman and Wang, 2010) and subsequent vasodilatation of both large conduit and resistance blood vessels (Wang et al., 2009b; Bradley et al.,…”
BackgroundZhang, Y., Lee, T.-S., Kolb, E. M., Sun, K., Lu, X., Sladek, F. M., Kassab, G. S., Garland, T., & Shyy, J. Y.-J. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000221230.08596.98 · Cited by 212 · cited 3×
“In eNOS knockout mice, shear stress- and bradykinin-mediated activation of AMPK is attenuated (Zhang et al., 2006; Wang et al., 2009a) and pharmacological inhibition of NOS prevents activation of AMPK by shear stress, bradykinin and calcium ionophores (Zhang et al.”
BackgroundRegulatory circuits controlling white versus brown adipocyte differentiation
Hansen, J. B., & Kristiansen, K. (2006) · Biochemical Journal · doi:10.1042/bj20060402 · Cited by 178
Metformin inhibits inflammatory response via AMPK-PTEN pathway in vascular smooth muscle cells
Kim, S. A., & Choi, H. C. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.07.165 · Cited by 149
Adipose tissue production of hepatocyte growth factor contributes to elevated serum HGF in obesity
Bell, L. N., Ward, J. L., Degawa-Yamauchi, M., Bovenkerk, J. E., Jones, R., Cacucci, B. M., Gupta, C. E., Sheridan, C., Sheridan, K., Shankar, S. S., et al. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00174.2006 · Cited by 121
MicroRNA Modulation of Cholesterol Homeostasis
Fernández-Hernando, C., & Moore, K. J. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.226688 · Cited by 89
Ewart, M.-A., Kohlhaas, C. F., & Salt, I. P. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.175919 · Cited by 57
Self-citation
Cited by
Yuan, T., Yang, T., Chen, H., Fu, D., Hu, Y., Wang, J., Yuan, Q., Yu, H., Xu, W., & Xie, X. (2019) · Redox Biology · doi:10.1016/j.redox.2018.09.025 · Cited by 743
Perivascular adipose tissue inflammation in vascular disease
Nosalski, R., & Guzik, T. J. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13705 · Cited by 398
Endothelial dysfunction in obesity
Engin, A. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-48382-5_15 · Cited by 255
The role of perivascular adipose tissue in obesity‐induced vascular dysfunction
Xia, N., & Li, H. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13650 · Cited by 206
“NO and H2S), prostacyclin, Ang 1–7, Ang II, methyl palmitate, ET-1 and ROS (e.g. superoxide, H2O2) (Gollasch, 2012; Szasz and Webb, 2012; Almabrouk et al., 2014; Tano et al., 2014).”
Zhang, Y., Shen, X., Xiao, X., Liu, M., Li, S., Yan, J., Jin, J., Gao, J., Zhen, C., Hu, N., et al. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13578 · Cited by 55
Metadata
- Authors
- Almabrouk, T. A. M., Ewart, M. A., Salt, I. P., & Kennedy, S.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2014-01-13
- Volume
- 171
- Issue
- 3
- Pages
- 595-617
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1511269911
- Cited by
- 80
- References
- 43
- FWCI
- 4.03
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.